Feds Want GSK VP To Testify In Wellbutrin Case

Law360, New York (April 20, 2011, 8:42 PM EDT) -- Prosecutors asked a Maryland federal judge Tuesday to force a GlaxoSmithKline PLC vice president to testify in the criminal case against a former GSK attorney accused of lying to health regulators about the marketing of antidepressant Wellbutrin.

Testimony from James Millar, GSK's vice president of strategic pricing, contracting and marketing, may help convict former GSK associate general counsel Lauren Stevens, and Millar may be reluctant to testify for fear of incriminating himself, prosecutors argue. 

Stevens is accused of interfering with a U.S. Food and Drug Administration...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

USA v. Stevens


Case Number

8:10-cr-00694

Court

Maryland

Nature of Suit

Date Filed

November 8, 2010

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.